ATARA BIOTHERAPEUTICS, INC. Public Float
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Public Float of $38.73 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $38.73M.
- 2024-06-30: Entity Public Float $41.04M.
- 2023-06-30: Entity Public Float $161.60M.
- 2022-06-30: Entity Public Float $715.38M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $38.73M 10-K · filed 2026-03-16 |
| 2024-06-30 | $41.04M 10-K · filed 2025-03-07 |
| 2023-06-30 | $161.60M 10-K · filed 2024-03-28 |
| 2022-06-30 | $715.38M 10-K · filed 2023-02-08 |
| 2021-06-30 | $1.15B 10-K · filed 2022-02-28 |
| 2020-06-30 | $906.90M 10-K · filed 2021-03-01 |
| 2019-06-28 | $760.74M 10-K · filed 2020-02-27 |
| 2018-06-29 | $1.08B 10-K · filed 2019-02-26 |
| 2017-06-30 | $271.25M 10-K · filed 2018-02-27 |
| 2016-06-30 | $457.20M 10-K · filed 2017-03-09 |
| 2015-06-30 | $698.30M 10-K · filed 2016-03-04 |
| 2014-06-30 | $0.00 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |